Course Directors


Directors of the course on Qualitative Methods in Global Infectious Diseases Research

 


Dr. Amrita Daftary, PhD, MPH
Assistant Professor, Global Health School of Health Policy and Management Dahdaleh Institute of Global Health Research, York University.

 

Dr. Nora Engel, PhD
Dr. Engel is associate professor of Global Health at Maastricht University. Her research focuses on innovation dynamics in global health challenges (mainly tuberculosis and HIV/AIDS) and on the sociology of diagnostics and innovations at the point-of-care. She has done extensive qualitative fieldwork in India and South Africa, among others on challenges to point of care testing across different settings, diseases and actor groups. She is a contributor on qualitative research to the advanced TB diagnostics course since 2012 and together with Amrita Daftary successfully launched the qualitative methods course in 2017.

 

Director of the course on Advanced TB Diagnostics

 

Dr. Madhukar Pai, MD, PhD, FCAHS
Dr. Pai is a Canada Research Chair in Translational Epidemiology & Global Health in the Department of Epidemiology, Biostatistics and Occupational Health at McGill University and the Associate Director of the McGill International TB Centre. He is a member of the Royal Society of Canada and a Fellow of the Canadian Academy of Health Sciences. His research program is focused on using translational epidemiology and implementation science to enhance tuberculosis care and control, so that products, knowledge and policies can translate into saved lives. He has coordinated multiple courses and workshops on epidemiology, modeling, systematic reviews and meta-analysis around the world.

 

Director of the course on Humanitarian Action in the 21st Century: Challenges and Dilemma

 

Rachel Kiddell-Monroe, LLM
Rachel Kiddell-Monroe is a lawyer and an activist focusing on humanitarian assistance, access to medicines, global health, governance and global health ethics. After working for several years with grassroots and indigenous organisations in Indonesia, Rachel joined Médecins Sans Frontières (MSF). She headed emergency humanitarian missions in Djibouti, Democratic Republic of Congo and Rwanda. After acting as programme director for MSF Canada, she became MSF’s Regional Humanitarian Affairs Advisor for Latin America based in Central America. She led a project to develop humanitarian medical assistance programmes in indigenous communities. She went onto lead the MSF Access Campaign in Canada and is now a member of MSF International Board of Directors. Rachel is also former President of Universities Allied for Essential Medicines (UAEM) and a Professor of Practice at McGill University. She lectures on international development and humanitarian action.

 

Directors of the course on Quality of TB Care

 

Dr. Madhukar Pai, MD, PhD, FCAHS
Dr. Pai is a Canada Research Chair in Translational Epidemiology & Global Health in the Department of Epidemiology, Biostatistics and Occupational Health at McGill University and the Associate Director of the McGill International TB Centre. He is a member of the Royal Society of Canada and a Fellow of the Canadian Academy of Health Sciences. His research program is focused on using translational epidemiology and implementation science to enhance tuberculosis care and control, so that products, knowledge and policies can translate into saved lives. He has coordinated multiple courses and workshops on epidemiology, modeling, systematic reviews and meta-analysis around the world, including week-long courses on advanced tuberculosis diagnostics research in Montreal for the past nine years.

 

Dr. Zelalem Temesgen, MD
Dr. Zelalem Temesgen MD is Professor of Medicine at Mayo Clinic, where he directs the Mayo Clinic HIV program, the Mayo Clinic Global HIV Education Initiative, and the Mayo Clinic Center for Tuberculosis. In addition to clinical responsibilities, Dr. Temesgen is actively involved in education and research both within Mayo Clinic and extramurally, participating in the clinical teaching curriculum for the Mayo Medical School and the Mayo Graduate School of Medicine as well as the Infectious Diseases Division. He is the founder of the Mayo Clinic Global HIV Education Initiative, which has developed a number of programs to enhance the knowledge and proficiency of health care providers worldwide. These include: Fundamentals of Global HIV Medicine, an HIV Management book intended for HIV medical care providers in resource limited settings, written by more than 60 subject matter experts from 15 countries; HIV eCurriculum series, an innovative, self-paced online program that has enrolled over 1600 learners in the United States and 700 professionals in Ethiopia; the tuberculosis eCurriculum Series, development of a web-based national Ethiopian curriculum on tuberculosis and leprosy; development of a web-based national Ethiopian curriculum on HIV testing and counseling; and HIV-Link, mobile phone-based clinical consultative support for HIV practitioners in rural Southern Ethiopia. Additional activities include media presentations, extramural visiting professorships and invited lectures at national and international meetings. Dr. Temesgen is the author of numerous publications, sits on the editorial boards of several medical journals, and is editor-in-chief of two books: Mayo Clinic Infectious Diseases Board Review Book and Fundamentals of Global HIV Medicine. Dr. Temesgen currently serves as the chair of the American Academy of HIV Medicine and a member of the US Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Dr. Temesgen has previously served as a member of the United States Presidential Advisory Council on HIV/AIDS as well as a member of the Scientific Advisory Board for The US President’s Emergency Plan for AIDS Relief (PEPFAR).

 

Dr. Jishnu Das
Jishnu Das is a professor at the McCourt School of Public Policy and the Walsh School of Foreign Service at Georgetown University. Jishnu’s work focuses on health and education in low and middle-income countries, with an emphasis on social markets, or common, but complex, conflagrations of public and private education and health providers operating in a small geographical space. As part of this research, he has co-developed the largest and longest-running cohort study on learning outcomes in low-income countries and has led an agenda on the measurement of healthcare quality in low-income countries. The methods he has developed are now being used by The World Bank in its Service Delivery Indicators as well as by multiple research groups in in India, Indonesia, South Africa, Kenya, Senegal and Tanzania. His research has shown how government can use information, funding and training programs to improve service delivery for the poor. His evaluations with multiple co-authors has led to the widespread adoption of a training program for informal providers (in West Bengal), health facility inspections (in Kenya) and networks for private sector providers (in India). He was also part of the team that developed India’s federal inpatient health insurance scheme, the RSBY, which reached 150 million people in 2016.Jishnu helped write the World Development Report on Gender and Development and in 2015 he was the Flander’s Visiting Professor at McGill University. He has received the George Bereday Award from the Comparative and International Education Society, the Stockholm Challenge Award for the best ICT project in the public administration category in 2006 and the Research Academy award from the World Bank in 2017 and 2013 for research on health and education. He is currently working on health inspections (Kenya), Tuberculosis (India) and education programs (Pakistan).

 

Directors of the course on Antimicrobial Resistance

 

Dr. Makeda Semret, MD, MSc, FRCPC
Dr. Semret is an Assistant Professor of Infectious Diseases and Medical Microbiology at the McGill University Health Centre and St-Mary’s Hospital Centre, and a visiting Faculty at Addis Ababa University (AAU, Ethiopia). She is a founding member of the AAU-McGill Partnership in Infectious Diseases (AMP-ID) which she currently co-directs. Her research is focused on assessing the burden of antimicrobial resistant (AMR) infections in low-resource settings, and the impact of laboratory diagnostics and antimicrobial stewardship interventions on patient outcomes and antimicrobial prescriptions in Ethiopia and in Canada. She has contributed to several of the Summer Institute courses (Tropical Medicine course since 2010, and Global Health Diagnostics course since 2015). She is the founding director of the AMR special session.

 

Dr. Erika Vlieghe, MD
Professor Erika Vlieghe is an infectious diseases clinician with professional experience within and outside Belgium (UK, Uganda, Ecuador, Cambodia). She studied medicine at the Leuven Catholic University, followed by a Postgraduate course in Tropical Diseases at the Antwerp Institute of Tropical Medicine (ITM) and a specialization in internal medicine and infectious diseases at the Leuven Catholic University. From 2004 to 2017 she has been working as a senior staff member and researcher at the ITM. Since 2017 she is heading the Department of General Internal Medicine, Infectious Diseases and Tropical Medicine at the University Hospital of Antwerp (UZA); she teaches capita selecta of tropical medicine and infectious diseases at various undergraduate and postgraduate courses at the University of Antwerp and the ITM. Over the past few years she has been involved in research and capacity building in the field of antibiotic resistance in low and middle income countries; she obtained a PhD in this field in 2014. From October 2014 – October 2015 Erika Vlieghe was temporarily appointed ‘National Ebola-coordinator’ in Belgium. Within this function she has worked in close collaboration with the national health authorities and many other partners to prepare the country for possible Ebola-infections.

 

Dr. Dao Nguyen is a clinician scientist, Associate professor of Medicine at McGill, investigator at the Research Institute of the McGill University Health Centre and Meakins Christie Laboratories, and attending staff in the Division of Respirology at the McGill University Health Centre. She has received her MD.CM (1997) and MSc Epidemiology (2004) degrees from McGill University, and completed her clinical training in Internal Medicine (New England Medical Center, Tufts University) and respirology (McGill University), and post-doctoral research training (2004-2009) at Seattle Childrens’ Hospital and the University of Washington. She is a Cystic Fibrosis Canada scholar, FRQS Clinicien Chercheur Boursier and Burroughs Wellcome Fund Career Award for Medical Scientist recipient. Her research is focused on the molecular microbiology and host-pathogen interactions of Pseudomonas aeruginosa, as well as antibiotic discovery and the mechanisms of antibiotic tolerance.

 

Directors of the course on Clinical Tropical and Geographic Medicine

 

Dr. Cédric Yansouni, MD, FRCPC DTM&H
Dr Yansouni is an Assistant Professor of Infectious Diseases and Medical Microbiology at the McGill University Health Centre in Montreal, where he serves as Associate Director of the J.D. MacLean Centre for Tropical Diseases. His research is focused on improving diagnostic tools and care for infectious diseases in remote or low resource settings, with an emphasis on enteric parasitic infections and diagnostic bacteriology. He is currently a technical advisor to the World Health Organization (WHO) for prequalification of diagnostics. He has been a founding co-Director of the Global Health Diagnostics Course since 2015 and has contributed to our Clinical Tropical Medicine Course since 2010.

 

Dr. Michael Libman, MD, FRCPC
Director of the J.D. MacLean Centre for Tropical Diseases at McGill University, Canada.Former Director of the Division of Infectious Diseases at McGill University and the McGill University Health Centre, Canada. He holds specialty certifications in Internal Medicine, Infectious Diseases, and Medical Microbiology from the Royal College of Physicians and Surgeons of Canada,and the academic rank of Professor in the Department of Medicine at McGill University. He has had a special interest in tropical medicine and parasitology throughout his career. He has worked at the McGill Centre for Tropical Disease for over 25years and has been the director for over 10 years. This is a unique clinical unit which combines daily tropical medicine clinics serving a wide variety of travelers, immigrants, and visitors, a large pre-travel clinic, a regional reference centre for clinical parasitology and the Canadian National Reference Centre for parasite serology and molecular diagnostics. He is currently Chair of the Committee to Advise on Tropical Medicine and Travel (CATMAT)for the Public Health Agency of Canada. He works as a visiting professor in the Infectious Disease training program at Addis Ababa University, Ethiopia and a co-director of the annual international course in tropical medicine given at the Christian Medical College in Vellore, India.Dr Libman also works as the consultant for infectious disease and microbiology for the Inuit communities of Nunavik in the Canadian eastern arctic region, where many of the infectious and diagnostic problems are similar to those found in the tropics.

 

Sapha Barkati, MD, MSc, DTM&H
Dr. Barkati is an Assistant Professor of Infectious Diseases and Medical Microbiology at the McGill University Health Centre. She is the educational director of the J.D MacLean Centre for Tropical diseases at McGill University and the medical director of the Centre Hospitalier de l’Université de Montréal travel clinic. Since 2018, she has become an established international faculty of the Gorgas Diploma Course, Instituto De Medicina Tropical “Alexander Von Humboldt”, Universidad Peruana Cayetano Heredia, Lima, Peru. Her research focus on the epidemiology of tropical and parasitic diseases and improvement of diagnostic and care of Strongyloides in at-risk individuals.

 

Directors of the course on Global Health Diagnostics

 

Dr. Cédric Yansouni, MD, FRCPC DTM&H
Dr Yansouni is an Assistant Professor of Infectious Diseases and Medical Microbiology at the McGill University Health Centre in Montreal, where he serves as Associate Director of the J.D. MacLean Centre for Tropical Diseases. His research is focused on improving diagnostic tools and care for infectious diseases in remote or low resource settings, with an emphasis on enteric parasitic infections and diagnostic bacteriology. He is currently a technical advisor to the World Health Organization (WHO) for prequalification of diagnostics. He has been a founding co-Director of the Global Health Diagnostics Course since 2015 and has contributed to our Clinical Tropical Medicine Course since 2010.

 

Dr. Nitika Pant Pai
Scientist, RI-MUHC Infectious Diseases and Immunity in Global Health Program Centre for Outcomes Research and Evaluation
Associate Professor, Department of Medicine, Faculty of Medicine, McGill University
Dr. Pai focuses on developing screening strategies for marginalized populations with point-of-care tests to improve screening and diagnosis, in order to make a public health impact. Her current work involves rapid point-of-care tests for HIV and related co-infections (hepatitis C, hepatitis B, syphilis) and the development of innovations that improve uptake of self testing for HIV, multiplex screening for HIV related co-infections for affected populations, and early screening for pregnant women in resource-limited settings.

 

Directors of the course on Strategies to End the HIV Epidemic

 

Dr. Chen Liang
Professor, Department of Medicine
Interim Director, McGill AIDS Centre
Dr. Chen Liang is a professor at the Department of Medicine, the Division of Experimental Medicine, an associate member at the Department of Microbiology & Immunology. He is the interim director of the McGill AIDS Centre. His laboratory is located at the Lady Davis Institute, Jewish General Hospital. His research focuses on understanding host immune restriction of HIV-1 infection. His group has discovered two of the few host restriction factors that have been reported to potently inhibit HIV-1. He has also applied the CRISPR gene editing technology for curing HIV-1 infected cells by targeting and eliminating infectious HIV-1 DNA. His group is dedicated to the discovery of HIV cure.

 

Dr. Marina Klein
Professor, Department of Medicine

 

Directors of the course on Advances in the Biology and Management of COVID-19

 

Dr. Chen Liang
Professor, Department of Medicine
Interim Director, McGill AIDS Centre
Dr. Chen Liang is a professor at the Department of Medicine, the Division of Experimental Medicine, an associate member at the Department of Microbiology & Immunology. He is the interim director of the McGill AIDS Centre. His laboratory is located at the Lady Davis Institute, Jewish General Hospital. His research focuses on understanding host immune restriction of HIV-1 infection. His group has discovered two of the few host restriction factors that have been reported to potently inhibit HIV-1. He has also applied the CRISPR gene editing technology for curing HIV-1 infected cells by targeting and eliminating infectious HIV-1 DNA. His group is dedicated to the discovery of HIV cure.

 

Dr. Matthew Cheng
Dr. Cheng is an Assistant Professor in the Department of Medicine at McGill University, in Montreal. He leads the medical mycology laboratory and practices clinical infectious diseases at the McGill University Health Centre.
Dr. Cheng obtained his medical degree from McGill University in 2011. He completed his residency in internal medicine at the University of British Columbia in 2014. Dr. Cheng returned to McGill University to pursue a combined fellowship in infectious diseases and medical microbiology, which he finished in 2017. He completed a postdoctoral fellowship at the Harvard Medical School affiliated Brigham and Women’s Hospital and Dana-Farber Cancer Institute in 2019 before establishing his clinical research program at the McGill University Health Centre.
Dr. Cheng’s research interests include treating patients with potentially lethal infectious diseases, such as those with severe manifestations of sepsis, bloodstream infections, and opportunistic infections in immunocompromised hosts. His research program focuses on improving outcomes in these conditions by developing novel treatment strategies and diagnostic assays. His group has already made significant contributions to the literature and has helped determine national and international treatment guidelines. His research program is funded by research operating grants from the US National Institutes of Health, the Canadian Institutes for Health Research, and the Australian National Health and Medical Research Council. Despite recently completing his postdoctoral fellowship, he has already published over 50 research papers. Dr. Cheng has been the recipient of numerous awards including fellowship grants from the Royal College of Physicians and Surgeons of Canada, the Association of Medical Microbiologists and Infectious Diseases Specialists of Canada, and the Fonds de Recherche Santé Quebec. He was also the recipient of the prestigious Terry Fox Humanitarian Award.